WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+17.78%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$9.17B
AUM Growth
+$646M
(+7.6%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
726
New
146
Increased
136
Reduced
152
Closed
261
Top Buys
| 1 |
TE Connectivity
TEL
|
$118M |
| 2 |
Ovintiv
OVV
|
$108M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$106M |
| 4 |
Amazon
AMZN
|
$86M |
| 5 |
Qorvo
QRVO
|
$80.1M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$238M |
| 2 |
Electronic Arts
EA
|
$107M |
| 3 |
Autodesk
ADSK
|
$95.8M |
| 4 |
Keysight
KEYS
|
$88.3M |
| 5 |
STMicroelectronics
STM
|
$82.2M |
Sector Composition
| 1 | Healthcare | 41.58% |
| 2 | Technology | 23.85% |
| 3 | Industrials | 10.4% |
| 4 | Energy | 8.49% |
| 5 | Consumer Discretionary | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Phreesia
PHR
$1.68B
| $6.78M | 0.07% |
292,822
-101,260
| -26% | -$2.34M |
|
277
Biomea Fusion
BMEA
$114M
| $6.75M | 0.07% |
464,573
+122,900
| +36% | +$1.78M |
|
278
Merus
MRUS
$5.1B
| $6.69M | 0.07% |
243,229
| – | – |
|
279
Caribou Biosciences
CRBU
$174M
| $6.54M | 0.07% |
1,140,671
+679,133
| +147% | +$3.89M |
|
280
Kenvue
KVUE
$35.7B
| $6.5M | 0.07% |
301,790
-181,726
| -38% | -$3.91M |
|
281
Fortrea Holdings
FTRE
$1.06B
| $6.5M | 0.07% |
+186,111
| New | +$6.5M |
|
282
Eagle Materials
EXP
$7.86B
| $6.47M | 0.07% |
+31,908
| New | +$6.47M |
|
283
Halozyme
HALO
$8.76B
| $6.42M | 0.07% |
+173,808
| New | +$6.42M |
|
|
DCPH
284
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.39M | 0.07% |
+396,239
| New | +$6.39M |
|
285
Watsco
WSO
$16.6B
| $6.38M | 0.07% |
+14,897
| New | +$6.38M |
|
286
Datadog
DDOG
$47.5B
| $6.28M | 0.07% |
+51,743
| New | +$6.28M |
|
287
PTC Therapeutics
PTCT
$4.55B
| $6.25M | 0.07% |
+226,942
| New | +$6.25M |
|
|
FNA
288
DELISTED
Paragon 28, Inc.
FNA
| $6.22M | 0.07% |
500,472
+108,208
| +28% | +$1.35M |
|
289
CVS Health
CVS
$93.6B
| $6.06M | 0.07% |
+76,788
| New | +$6.06M |
|
290
Legend Biotech
LEGN
$6.66B
| $6.02M | 0.07% |
100,000
| – | – |
|
291
Molina Healthcare
MOH
$9.47B
| $5.97M | 0.06% |
16,513
-15,085
| -48% | -$5.45M |
|
292
Zoom
ZM
$25B
| $5.86M | 0.06% |
+81,492
| New | +$5.86M |
|
293
MSC Industrial Direct
MSM
$5.14B
| $5.85M | 0.06% |
+57,731
| New | +$5.85M |
|
294
NovoCure
NVCR
$1.37B
| $5.84M | 0.06% |
+391,459
| New | +$5.84M |
|
|
GRVY
295
GRAVITY
GRVY
$444M
| $5.81M | 0.06% |
+83,478
| New | +$5.81M |
|
296
Aurinia Pharmaceuticals
AUPH
$1.63B
| $5.8M | 0.06% |
645,194
+145,194
| +29% | +$1.31M |
|
297
Dyne Therapeutics
DYN
$2.02B
| $5.79M | 0.06% |
435,526
+99,642
| +30% | +$1.33M |
|
298
Arcellx
ACLX
$4.03B
| $5.78M | 0.06% |
+104,060
| New | +$5.78M |
|
299
Bloomin' Brands
BLMN
$605M
| $5.73M | 0.06% |
203,434
-244,643
| -55% | -$6.89M |
|
300
Travere Therapeutics
TVTX
$1.93B
| $5.72M | 0.06% |
636,621
-1,513,944
| -70% | -$13.6M |
|